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Abstract  
Objective: The aim of this study is to evaluates the effects of breast cancer states on Some 
blood biomarkers in female patients. Materials and methods: 16 cases of women breast 
cancer were chosen, 20 age matched controls were chosen. Blood samples were collected 
from them and blood glucose, lipid profile, Sodium, Potassium and Chloride levels were 
measured. Also, RBC, HGB, HCT, LYM, MON and EOS levels in blood was measured. 
Results: results of biochemical parameters revealed that a significant increase in blood 
glucose (P <0.05) and calcium (P <0.01) level and a significant decrease (P <0.01) in 
serum potassium concentration and no significant change in serum lipid profile, Na and Cl 
level in women with breast cancer compared to controls.  On the other hand, Results of the 
haematological analysis show that RBC (p <0.001), HGB (p <0.01), HCT (p <0.05), 
lymphocyte and eosinophil (p <0.01) level are significantly decreased and monocyte level is 
significantly elevated (p <0.01) in patients group as the control group. Conclusion: In 
conclusion, the present study suggests that the importance of some haematological and 
serum electrolyte parameters as markers of diagnosis and therapeutic follow-up of the 
breast cancer disease in women. 
Keywords: Breast cancer; Haematological parameters; Electrolyte. 
Introduction 
Breast cancer is the type of cancer that develops from breast tissue; it is especially common among women and is one of 
the most studied diseases, largely because of its high mortality rate [1].Very difficult to determine the cause of breast 
cancer, but Studies scientists have shown that some person-specific characteristics or behaviors were more often 
observed in women who had breast cancer than in other women [2]. Risk factor to obtain breast cancer increases with 
inherited genetic mutations, such as in the BRCA1 and BRCA2 genes, and a personal or family history of breast cancer 
[3]. Other risk factors include never having children, greater height, benign breast disease, early menarche, late 
menopause (after age 54), ionizing-radiation Exposure, postmenopausal obesity, physical inactivity, and alcohol intake 
[4, 5]. Breastfeeding, moderate/vigorous physical activity, and maintaining a healthy body weight decrease breast cancer 
risk [6, 7]. High breast tissue density [8]. In Algeria, breast cancer is the first leading cancer for women. With 11.000 
new cases/year. Epidemiological features of breast cancer appear to be different in developing countries compared to 
Western countries [9]. Breast cancer care consists of a multidisciplinary approach of surgery, radiation, and systemic 
therapy including chemotherapy. Biological markers for breast cancer are biomolecules that result from cancer-related processes 
and are associated with particular clinical outcomes; they thus help predict responses to therapy [10]. The treatment options 
available are surgery, radiation, chemotherapy, immunotherapy and targeted therapy [11]. With this background the 
present study was undertaken to assess the level of biochemical and hematological markers and the alterations in the 
levels of serum electrolytes in women Breast cancer patients and normal subjects.  
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Subject and Methods 
Subject 
Ethical approval (Appendix) was sought and approved by the Ethical Committee of the Department of Cellular and 
Molecular Biology, Faculty of natural science and life, University of El Oued. We studied is carried out on 36 volunteer 
women of age between 25 -80 years, were divided into two groups; a group of 20 healthy control women with mean age 
42.82 ± 1.20 years, the other group of 16 patients women diagnosed and treated breast cancer with mean age 45.48 ± 
1.37 years. 
Inclusion Criteria 
Patients who had clinical diagnosis and laboratory findings of breast cancer disease for more than three months 
evidenced 
Exclusion Criteria 
To eliminate the factors which might affect haematological parameters, we excluded all diabetics, anemia and other 
chronic diseases subjects from patient groups and healthy controls. 
Methods and Laboratory Investigations 
Fasting blood samples were collected and placed into containing tubes. Blood was transferred into EDTA tubes for 
haematological studies and the serum were obtained after centrifugation at 3000 × g for 5 min, removed and retained for 
assay of the level of glucose, biochemical and all the electrolytes parameters. Serum samples were stored at -20°C until 
analysis.  Hematological analysis (FNS) is performed by the hematology autoanalyzer (Sysmex). Serum Electrolyte 
levels (Na+, k+ & Cl-) were determined by Electrolyte Analyzer (Easylute PLUS Na/K/Cl de Medica). Triglyceride 
(TG), Total cholesterol (TC), and Total protein concentrations were measured using commercial kits (Spinreact) (refs: 
TG-1001311, TC-1001090 and total proteins-1001291).    
Statistical Methodology 
The reported data are the means of measurements and their standard error of mean (SEM) values. The results of cases 
and controls were compared by student test using SPSS software. 
Results and Discussion 
Biochemical Mmarkers  
Our results obtained concerning biochemical parameters (table 01) revealed that a significant increase (P <0.05) in blood 
glucose level in women with breast cancer compared to controls. Also, our results show that there is no significant 
change (P> 0.05) concerning the serum lipid profile parameters in the groups studied. Accumulation of TGs, TC and 
LDL-C is one of several risk factors in Coronary Heart Disease (CHD) [12]. That elevated glucose consumption is a 
necessary component of carcinogenesis. Specifically Gillies RJ et al. [13] propose that glycolysis is elevated because it 
produces acid, which provides an evolutionary advantage to cancer cells. In 2002, the prospective Morimoto et al. study 
found that high fasting glucose was a risk factor for breast cancer, further supported by a second Morimoto et al. study 
with longer follow-up [14]. 
Table 01: Mean glucose level and biochemical markers in control and patient. 
Parameters 
Control 
N=20 
Patients 
N=16 
P 
Glucose (g/l) 0.7865±0.0308 1.093±0.121 0.024 
Cholesterol (g/l) 1.8330±0.0957 1.916±0.126 0,522 
Triglyceride (g/l) 0.896±0.186 1.048±0.173 0,393 
HDL cholesterol (g/l) 0.4906±0.0323 0.4520±0.0319 0,246 
LDL cholesterol (g/l) 1.1900±0.0950 1.205±0.113 0,899 
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VLDL (g/l) 0.1715±0.0374 0.2096±0.0346 0,287 
Serum Electrolytes Markers  
The result of blood electrolyte analysis (table 02.) shows that serum potassium concentration is significant decrease (P 
<0.01) and serum calcium level is significant increase (P <0.01) in the breast cancer group against the control. On the 
other hand there were no significant change in serum Na and Cl concentration. Yadav & Khodke, (2015) show that the 
serum potassium levels in cancer patients was slightly higher than the normal but statistically significant (p ˂0.05) as 
compared to normal healthy controls [15]. The primary role of electrolytes lies in the maintenance of body ionic and 
water balance. Thus the requirements for strong ions that have characteristic effects on body fluids homeostasis, cannot 
be considered individually because it is the overall balance that is important [16]. Higher levels of serum potassium may 
be due to several reasons such as side effects of chemotherapeutic drugs, breakdown of tumor cells, hormones produced 
by certain types of tumors and extensive replacement of the adrenal glands by tumors can all result in high potassium 
blood levels. According to Yan Cui and Thomas E. Rohan that the importance of calcium in carcinogenesis derives from 
its participation in regulating cell proliferation, differentiation, and apoptosis [17]. Russo & Russo, (2001) also found that 
there is increasing in the concentration of calcium  decreases  cell proliferation and induces differentiation of mammary 
cells in experimental studies [18]. Evidence is available that calcium at least partially exerts its anticarcinogenic effects 
through vitamin D. For example, calcium is one of the key mediators of apoptosis induced by vitamin D compounds in 
breast cancer cells [19]. 
Table 02: Serum electrolyte and calcium level in patients group and control. 
Parameter 
Control 
N=20 
Patients 
N=16 
P 
Serum Na (mmol/l) 140.92± 1.15 139.84±0.66 0,119 
Serum K (mmol/l) 4.714±0.134 4.214±0.131 0,002 
Serum Cl (mmol/l) 105.69±1.39 104.41±0.79 0,130 
Serum Ca (mg/l) 83.50±1.81 90.38±2.19 0,007 
Haematological Markers 
Seen from Table 03, Results of the hematological analysis show that the erythrocyte line (RBC, HGB, HCT) is 
significantly decreased (p <0.001; p <0.01 and p <0.05) respectively in patients group as the control group. Our results 
are in agreement with the results of Shrivastava et al. [20] that got that found a significantly lower of hemoglobin level 
and RBC count in women with breast cancer as compared to control healthy subjects. Moreover our results illustrate that 
a significant elevation (p <0.01) of monocyte, and a significant decrease of lymphocyte (p <0.01) and eosinophil (p 
<0.001), in the patients to the controls. The total and differential WBC and lymphocyte count is an important auxiliary 
diagnostic test as changes occur with systemic inflammation and other diseases [21. KHAN et al. [22 also found the 
percentage of monocytes and lymphocytes were agreement with results of the present study. Preeti et al. (2016) showed 
that No significant variation was observed for neutrophils, Eosinophil and monocyte count during the different courses of 
chemotherapy treatment in cancer patients [23]. Nitric oxide (NO) is a highly reactive free radical with a multitude of 
organ which induce oxidative stress [24]. Oxidative stress is defined as an imbalance in the balance between antioxidants 
and pro-oxidants in favor of antioxidants. [25]. There is a complex interaction between antioxidants and oxidants such as 
reactive oxygen species, which modulates the generation of oxidative stress [26]. The results found were opposite to 
those observed in Swati et al (2017) [27] who showed that platelet were non-significant change as compared to control 
healthy subjects. Variation in hematological parameters in breast cancer patients may be due to the increase in the levels 
of pro-inflammatory cytokines Including Interlukin-1 and Interlukin-6 and Tumor necrosis factor [28].  
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Table 03: Hematology parameter in the blood of control women and cancerous women. 
Parametre 
Control 
N=20 
Patients 
N=16 
P 
Red blood cell  (RBC)  (10
6
/ul) 4.2200±0.0674 3.628±0.131 0,000 
Hemoglobin (HGB) (g/dl) 11.320±0.295 10.013±0.364 0,003 
Hematocrit (HCT) (%) 35.245±0.839 31.44±1.01 0,002 
Lymphocytes (10
3
/ul) 2.110±0.179 1.515±0.161 0,002 
Monocytes (10
3
/ul) 0.3600±0.0331 0.5467±0.0609 0,008 
Eosinophyle (10
3
/ul) 0.2125±0.357 0.680±0.0153 0,000 
Conclusion 
In conclusion, the present study suggests that the biochemical parameters are of little importance in the prognosis of 
breast cancer but show the importance of hematological parameters as markers of diagnosis and therapeutic follow-up of 
the disease Also, electrolyte disturbances need to be monitored and treated appropriately to avoid the ill effects resulting 
from the changes in the serum levels of these cations. 
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